drugset / Trial / NCT00263198
PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety of PTK787/ZK222584 and Letrozole when given in combination, and to see what effects they have on breast cancer that has metastasized.
Timeline
- Start
- 2006-03
- Primary completion
- 2006-10
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 2.5 mg | Oral |
| Subject | vatalanib | Small molecule | 500 mg | Oral |
| Subject | vatalanib | Small molecule | 750 mg | Oral |